WILMINGTON, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares announced today the appointment of Jeffrey W. Lunsford to its board of directors. Lunsford has also been appointed to the board of directors of Live Oak Bank. “As a successful entrepreneur and financial technology expert, Jeff brings a deep level of technical expertise to our board,” said Live Oak Bancshares Chairman and CEO James S. (Chip) Mahan III. “His skill sets are an excellent match for Live Oak as we continue to redefine what it ...

ATHENS, Greece, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (together with its subsidiaries, unless context otherwise dictates, “OET” or the “Company”) (NYSE: ECO, OSE: OET) today reported its unaudited condensed financial results for the second quarter and six-month period of 2025, which are attached to this press release. Financial performance of the Second Quarter Ended June 30, 2025 Revenues of $93.9 million in Q2 2025, compared to $112.0 million in Q2 2024.Profit of $26.9 million in Q2 ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Customers arrive at a Cava restaurant in New York City on June 22, 2023.Cava on Tuesday lowered its full-year forecast for same-store sales growth after a disappointing second quarter.For the full year, Cava now anticipates same-store sales growth of 4% to 6%, down from its prior range of 6% to 8%.Shares of the company plunged 20% in extended trading. The stock has fallen 40% this year, including the after-hours move.Here's what the company reported compared with what Wall Street was expecting, based on a s ...

DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D’Elia, have resigned from their positions and employment with the Company. As part of the leadership changes, Leslie C.G. Campbell, the Chair of the Company’s Board of Directors (the “Board”), has assumed the role of Interim Chief Executive Officer, and Douglas ...

Monday.com Ltd. MNDY reported a rise in sales for the second quarter on Monday.The software company posted revenue of $299 million, up 27% year over year, driven by strong demand from enterprise customers and growth in its customer base. The company also added a record number of net new customers generating over $100,000 in annual recurring revenue (ARR), while its monday CRM product reached $100 million in ARR just three years after launch.Looking ahead, Monday.com expects third-quarter revenue of $311 mil ...

Core Insights - Solid Biosciences is advancing its pipeline with three clinical-stage programs targeting neuromuscular and cardiac diseases, including SGT-003 for Duchenne Muscular Dystrophy, SGT-212 for Friedreich's Ataxia, and SGT-501 for Catecholaminergic Polymorphic Ventricular Tachycardia [2][4][9] Clinical Trials and Pipeline - The Phase 1/2 INSPIRE DUCHENNE trial has dosed 15 participants, with ongoing recruitment and no serious adverse events reported [1][3][5] - SGT-212 and SGT-501 are expected to initiate Phase 1b trials in Q4 2025, with SGT-212 being the first gene therapy for Friedreich's Ataxia utilizing a dual route of administration [1][4][6][9] - A randomized, double-blind, placebo-controlled trial for SGT-003 is planned outside the U.S. in Q4 2025 to support global regulatory authorizations [5] Financial Position - As of June 30, 2025, the company reported $268.1 million in cash and equivalents, providing a cash runway into H1 2027 [1][8] - Research and Development expenses for Q2 2025 were $32.4 million, up from $19.5 million in Q2 2024, primarily due to increased costs associated with SGT-003 [8][13] - The net loss for Q2 2025 was $39.5 million, compared to $25.1 million in Q2 2024, reflecting increased operational expenses [13][15] Strategic Partnerships and Technology - Solid has executed over 25 agreements for the use of its proprietary AAV-SLB101 capsid with academic labs and institutions [1][9] - The company is developing multiple next-generation capsid and promoter libraries, with the first cardiac capsid library selection expected in Q4 2025 [9] Market Position and Mission - Solid Biosciences is focused on improving the lives of patients with rare diseases, leveraging its expertise in genetic medicine to innovate therapies for conditions like Duchenne and Friedreich's Ataxia [2][11]

Core Viewpoint - York Water (YORW) reported quarterly earnings of $0.35 per share, exceeding the Zacks Consensus Estimate of $0.33 per share, with a year-over-year comparison showing no change in earnings [1][2] Financial Performance - The company achieved revenues of $19.2 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.05%, compared to $18.75 million in the same quarter last year [2] - Over the last four quarters, York Water has exceeded consensus EPS estimates only once [2] Stock Performance - York Water shares have declined approximately 5.5% since the beginning of the year, while the S&P 500 has gained 8.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.41 on revenues of $21 million, and for the current fiscal year, it is $1.33 on revenues of $78 million [7] - The trend of estimate revisions for York Water was mixed prior to the earnings release, which may change following the recent report [6] Industry Context - The Utility - Water Supply industry, to which York Water belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Financial Performance - Company reported record revenues of $23.1 million for the second quarter of 2025, an increase of 15% from $20.1 million in the first quarter of 2025 and 8% from $21.4 million in the second quarter of 2024 [2][8][14] - Gross profit for the second quarter of 2025 increased by 23% to $7 million, with a gross margin of 30.3%, up 7% sequentially from the first quarter of 2025 [2][9] - Net cash used in operating activities decreased by 54% to $2 million in the second quarter of 2025 compared to $4.3 million in the first quarter of 2025 [2][8] Cash Position - As of June 30, 2025, the company reported $15.7 million in cash, cash equivalents, and restricted cash, up from $12.3 million as of March 31, 2025 [2][10] - The company leverages its trades payable to finance operations, enhancing its cash position and lowering its cost of capital [10] Strategic Collaborations - Entered into a major collaboration with a $3 billion mixed-use smart city project in Miami, expected to supply over 500,000 units of its advanced smart home technologies [2][5] - Announced a sales and marketing collaboration with Parrot Uncle, a leading ceiling fan manufacturer, to jointly market SKYX's technologies [5] Product Development - Announced a surge in demand for its new patented all-in-one smart turbo heater and ceiling fan, targeting a multi-billion-dollar market [3][5] - The company has secured additional equity through preferred stock investments totaling approximately $15 million, indicating strong confidence from insiders [11] Market Expansion - Collaborating with major retailers like Home Depot and Wayfair to expand product offerings in both retail and professional segments [5][16] - The company is focused on growing its market penetration in the U.S. and Canada through its e-commerce platform of 60 websites [5][17] Safety and Standardization - The safety code standardization team is making progress with significant support from industry leaders, aiming for mandatory safety standards for its technologies [13] - The company believes its products can significantly reduce risks such as fires and electrocutions, potentially saving insurance companies billions annually [13]

Core Viewpoint - Vinci Compass Investments Ltd. reported strong financial results for the second quarter of 2025, highlighting solid fundraising momentum and strategic initiatives across its platform [2]. Financial Performance - Fee Related Earnings (FRE) for the second quarter of 2025 were R$65.2 million, equating to R$1.03 per common share [4]. - Adjusted Distributable Earnings for the same period were R$75.8 million, or R$1.20 per common share [4]. Dividends - The company declared a quarterly dividend of US$0.15 per share, payable on September 9, 2025, to record holders as of August 25, 2025 [3]. Company Overview - Vinci Compass is a leading provider of alternative investments and global solutions in Latin America, with nearly three decades of experience and operations in eleven offices across Latin America and the US [6]. - As of June 2025, the company managed R$304 billion in assets under management and advisory [6].